Abstract |
The effect of thymosin fraction 5 (TF5) on the promotion and progression phases of urinary tract carcinogenesis induced by consecutive administration of phenacetin and N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) in NON/Shi mice was investigated. The study was carried out twice with a minor modification to the protocol in the second experiment. Fifty-seven male NON/Shi mice in experiment 1 and 100 mice in experiment 2 were each divided into four groups. Phenacetin was administered for 8 weeks in experiment 1 and 12 weeks in experiment 2, and subsequently BBN was given for 6 weeks in both cases, for total observation periods of 30 and 34 weeks, respectively. Sixty micrograms of TF5 per mouse was inoculated subcutaneously twice a week during (group 2) or after (group 3) BBN exposure, or both periods (group 4). Group 1 served as a control group without TF5 treatment. Histopathological examination revealed no effects on either induction of urinary tract carcinomas or distant metastasis from renal pelvic carcinomas in either experiment.
|
Authors | T Murai, H Iwata, S Mori, F Hato, S Kimura, Y Kinoshita, S Wada, T Kishimoto, S Makino, T Oohara |
Journal | Oncology research
(Oncol Res)
Vol. 7
Issue 3-4
Pg. 139-44
( 1995)
ISSN: 0965-0407 [Print] United States |
PMID | 8555647
(Publication Type: Journal Article)
|
Chemical References |
- Carcinogens
- Phytohemagglutinins
- thymosin fraction 5
- Concanavalin A
- Butylhydroxybutylnitrosamine
- Thymosin
- Phenacetin
|
Topics |
- Animals
- Butylhydroxybutylnitrosamine
(toxicity)
- Carcinogens
(toxicity)
- Cocarcinogenesis
- Concanavalin A
(pharmacology)
- Drug Interactions
- Lymphocytes
(drug effects, immunology)
- Male
- Mice
- Mice, Inbred Strains
- Phenacetin
(toxicity)
- Phytohemagglutinins
(pharmacology)
- Spleen
(cytology, drug effects, immunology)
- Thymosin
(analogs & derivatives, toxicity)
- Urologic Neoplasms
(chemically induced)
|